CB50785-21 - 0x0000000000006DEF
Healthy Males & Females
Forward
* Stipend may pay up to reflected amount.
Start Date:
October 11, 2026 - 3:00pm
End Date:
October 26, 2026 - 9:30am
Study Details
Study Number: CB50785
Group Number: 21
Study Requirement: Healthy Normal Male and Female
Stipend: up to $6,000.00
Study Criteria
Age: 19 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 111 lbs
Study Information
Indication: This investigational medication is being developed for the treatment of multiple sclerosis (MS).
Route of Administration: Oral
Blood Draws: 34
Study Schedule
Schedule Type: Long Term
Study Length: 9 Night Stay & 2 Returns
Screening Dates:
| Event Day | Event Date |
|---|---|
| Friday | 9/25/2026 |
| Monday | 9/28/2026 |
| Tuesday | 9/29/2026 |
| Monday | 10/5/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Friday | 9/25/2026 |
| Monday | 9/28/2026 |
| Tuesday | 9/29/2026 |
| Monday | 10/5/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Sunday | 10/11/2026 3:00:00 PM | Tuesday | 10/20/2026 10:30:00 AM | 1 | Lincoln |
| Return | Thursday | 10/22/2026 8:30:00 AM | Thursday | 10/22/2026 9:30:00 AM | 1 | Lincoln |
| Return | Monday | 10/26/2026 8:30:00 AM | Monday | 10/26/2026 9:30:00 AM | 1 | Lincoln |
